SCHOENBERG MARK (Chief Medical Officer) sold 3.6% of their position (5.22K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $142.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/9/2026ACC: 0001437749-26-019964
Officer· Chief Medical Officer
Since Jan 2019
-5.22K
Net shares
Net seller
$142.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 15.22K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+10K
Price / share
—
Trade value
—
% of position
7.4%
6/8/2026
134.99K→144.99K
Ordinary Shares
Direct
Shares
−5.22K
Price / share
$27.30
Trade value
$142.56K
% of position
3.6%
6/8/2026
144.99K→139.76K
Total
Net shares
+4.78K
Net value
-$142.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/8/2026 | M · Option Exercise | +10K | — | — | 7.4% | 134.99K | 144.99K |
| Ordinary Shares Direct | 6/8/2026 | S · Sale | −5.22K | $27.30 | $142.56K | 3.6% | 144.99K | 139.76K |
| Total | +4.78K | -$142.56K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Ordinary Shares
10K shares
Shares
−10K
Strike price
Held after
0.00
Exercisable
—
6/8/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares10K shares | 6/8/2026 | M · Option Exercise | −10K | — | 0.00 |